The Rising Pound Will Hit GlaxoSmithKline plc, BHP Billiton plc, ARM Holdings Plc, AstraZeneca plc And Diageo plc

The strong pound has a sting in the tail for investors in GlaxoSmithKline plc (LON:GSK), BHP Billiton plc (LON:BLT), ARM Holdings Plc (LON:ARM), AstraZeneca plc (LON:AZN) and Diageo plc (LON:AZN)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A strong currency is a sign of global punching power, but it can leave investors on the ropes.

Sterling’s resurgence has dealt a few body blows to the FTSE 100, whose constituents generate more than three-quarters of their earnings overseas.

As the pound rises from the canvas, up 10% this year against a basket of currencies, some major UK companies are feeling a bit punchdrunk.

Astra’s Weaker

Global research-based pharmaceutical company AstraZeneca (LSE: AZN) is one of them. Of every £1 it earns, less than 9p comes from the UK. But its company headquarters are in Cambridge, while 8,000 of its 51,700 staff are based in the UK. They like to be paid in pounds.

So while overseas income is falling in relative terms, its UK cost base isn’t. Reporting in dollars shields AZN from some of today’s currency shifts, but its dollar dividends are now worth less to income seekers. At today’s exchange rate of $1.71, they’re earning 14% less than they did when the pound languished at $1.50. That’s a blow, given that the yield has fallen to 3.8% lately as the share price has recovered.

Glaxo’s Currency Worry

Pharma rival GlaxoSmithKline (LSE: GSK) also earns less than 9p in every £1 overseas. Its disappointing Q1 results were based on exchange rates of $1.66, €1.21 and Yen 171, and management was complaining about currency headwinds then. It said if currency rates held at that level for the rest of the year, it would knock an estimated 7% of 2014 sterling turnover, and 11% off core earnings per share. Today, the pound buys $1.71, €1.26 and Yen 173, so matters have got worse.

At least Glaxo’s dividends are priced in pounds, while the yield has risen to 5% on recent share price weakness. Investors have other matters on their mind right now, as the sex and bribery scandal intensifies.

BHP Billiton Digs Deeper

Big miners such as BHP Billiton (LSE: BLT) generate almost all their earnings overseas, but since they report in dollars, the impact of the stronger pound is limited. BHP’s dividends are also paid in dollars, however, so the real value of its 3.4% yield to UK investors has slipped.

Shifting metals prices will have a bigger impact on shareholder decisions. Aluminium has been rising lately, as motor manufacturer Ford shifts to the lighter metal to boost fuel-efficiency, but iron ore has been falling, and copper is volatile. Dollar weakness will support commodities that are priced in the greenback, but if the Fed stops hiking base rates, that could reverse.

Diageo To Go

Adverse currency movements were implicated in the 7.4% drop in sales at global drinks giant Diageo (LSE: DGE), as falling emerging markets currencies hit consumer demand. The sale of Jose Cuervo, political instability in Thailand and a Chinese crackdown on gift giving were also sobering.

Diageo’s dividend is priced in pounds, so that’s something, although at 2.6%, not that much. I banked a large slug profit on Diageo last year and the share price is down 10% since then. As the glory years of growth appear to have slowed, I’m in no rush to return.

ARM Is Harmed

ARM Holdings (LSE: ARM) has more to worry about than currency headwinds. Analysts are predicting a drop in Q2 revenues next week, as demand for smartphones and tablets slows. But foreign exchange shifts still have an impact on its numbers. ARM’s total Q1 dollar revenues rose 16% year-on-year, but only 10% in sterling terms. After years of breakneck growth, the share price is down 10% in the past 12 months. We’ll know more about ARM’s prospects next week.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool recommends GlaxoSmithKline and ARM Holdings.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »